North America Clinical Trial Services Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
North America clinical trial supplies market is projected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.
The key market players for North America clinical trial services market are listed below:
On the basis of therapeutic use the North America clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.
On the basis of end user the North America clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.
Based on countries, the market is segmented into counties:
The report covers the present scenario and the growth prospects of the North America clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Prominent factors driving the growth of this market are demand in clinical trials worldwide, Increasing Incidences of diseases, government funds to R&D investments and development of new treatments such as personalized medicine leading the clinical trial supplies market to grow in the future in market.
The key market players for North America clinical trial services market are listed below:
- Thermo Fisher Scientific Inc.,
- Catalent, Inc.
- Clinigen Group plc.
- PAREXEL International Corporation
- PCI Pharma Services
- Almac Group
- PAREXEL International Corporation
- KLIFO
- Bionical Ltd.
- Alium Medical Limited
- MYODERM
- Clinigen Group plc.
- Ancillare, LP
- SIRO Clinpharm
- CLINICAL SUPPLIES MANAGEMENT HOLDINGS, Inc.
- Services
- Clinical phases
- Therapeutic uses
- End User
On the basis of therapeutic use the North America clinical trial supplies market is segmented into oncology, cardiovascular disease, dermatology, metabolic disorders, infectious diseases, respiratory diseases, CNS and mental disorders, blood disorders and others.
On the basis of end user the North America clinical trial supplies market is segmented into contract research organizations and pharmaceutical and biotechnology companies.
Based on countries, the market is segmented into counties:
- U.S.
- Canada
- Mexico
The report covers the present scenario and the growth prospects of the North America clinical trial supplies market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1 INTRODUCTION
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Clinical Trial Supplies Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 DBMR Market Challenge Matrix
2.8 Secondary Sources
2.9 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Demand Of Clinical Trials Worldwide
3.1.2 Increasing Incidences Of Diseases
3.1.3 Government Funds To R&D Investments
3.1.4 Development Of New Treatments Such As Personalized Medicine
3.2 Restraints
3.2.1 Adverse Effects Of Clinical Trials
3.2.2 Transportation Issue
3.3 Opportunities
3.3.1 New Drug Development And Availability In Emerging Countrires
3.4 Challenges
3.4.1 Longer Procedure Time Of Clinical Trials Approval
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES
6.1 Overview
6.2 Storage
6.3 Manufacturing
6.4 Packaging And Labeling
6.5 Distribution
7 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES
7.1 Overview
7.2 Phase Iii
7.3 Phase Ii
7.4 Phase Iv
7.5 Phase I
8 MJKNORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
8.1 Overview
8.2 Oncology
8.3 Cardiovascular Disease
8.4 Dermatology
8.5 Metabolic Disorders
8.6 Infectious Disease
8.7 Respiratory Diseases
8.8 Cns And Mental Disorders
8.9 Blood Disorders
8.10 Others
9 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER
9.1 Overview
9.2 Contract Research Organizations
9.3 Pharmaceutical And Biotechnology Companies
10 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY GEOGRAPHY
11 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, COMPANY LANDSCAPE
11.1 Company Share Analysis: North America
12 COMPANY PROFILE
12.1 Thermo Fisher Scientific Inc.
12.1.1 Company Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Catalent, Inc.85
12.2.1 Company Overview
12.2.2 Revenue Analysis
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Clinigen Group Plc.
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Revenue Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Parexel International Corporation
12.4.1 Company Overview
12.4.2 Revenue Analysis
12.4.3 Company Share Analysis
12.4.4 Product Portfolio
12.4.5 Recent Developments
12.5 Alium Medical Limited
12.5.1 Company Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.6 Almac Group
12.6.1 Company Overview
12.6.2 Geographic Presence
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Ancillare, Lp
12.7.1 Company Overview
12.7.2 Geographic Presence
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 Biocair
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments
12.9 Bionical Ltd.
12.9.1 Company Overview
12.9.2 Gepographic Presence
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Clinical Supplies Management Holdings, Inc.
12.10.1 Company Overview
12.10.2 Geographic Presence
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.11 Klifo
12.11.1 Company Overview
12.11.2 Geographic Presence
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Movianto
12.12.1 Company Overview
12.12.2 Geographic Presence
12.12.3 Product Portfolio
12.12.4 Recent Developments
12.13 Myoderm
12.13.1 Company Overview
12.13.2 Geographic Presence
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Pci Pharma Services
12.14.1 Company Overview
12.14.2 Geographic Presence
12.14.3 Product Portfolio
12.14.4 Recent Developments
12.15 Sharp
12.15.1 Company Overview
12.15.2 Geographic Presence
12.15.3 Product Portfolio
12.15.4 Recent Developments
12.16 Siro Clinpharm
12.16.1 Company Overview
12.16.2 Geographic Presence
12.16.3 Product Portfolio
12.16.4 Recent Developments
13 RELATED REPORTS
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Clinical Trial Supplies Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Covered
2 MARKET SEGMENTATION
2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 DBMR Market Challenge Matrix
2.8 Secondary Sources
2.9 Assumptions
3 MARKET OVERVIEW
3.1 Drivers
3.1.1 Rising Demand Of Clinical Trials Worldwide
3.1.2 Increasing Incidences Of Diseases
3.1.3 Government Funds To R&D Investments
3.1.4 Development Of New Treatments Such As Personalized Medicine
3.2 Restraints
3.2.1 Adverse Effects Of Clinical Trials
3.2.2 Transportation Issue
3.3 Opportunities
3.3.1 New Drug Development And Availability In Emerging Countrires
3.4 Challenges
3.4.1 Longer Procedure Time Of Clinical Trials Approval
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES
6.1 Overview
6.2 Storage
6.3 Manufacturing
6.4 Packaging And Labeling
6.5 Distribution
7 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES
7.1 Overview
7.2 Phase Iii
7.3 Phase Ii
7.4 Phase Iv
7.5 Phase I
8 MJKNORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
8.1 Overview
8.2 Oncology
8.3 Cardiovascular Disease
8.4 Dermatology
8.5 Metabolic Disorders
8.6 Infectious Disease
8.7 Respiratory Diseases
8.8 Cns And Mental Disorders
8.9 Blood Disorders
8.10 Others
9 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY END USER
9.1 Overview
9.2 Contract Research Organizations
9.3 Pharmaceutical And Biotechnology Companies
10 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, BY GEOGRAPHY
11 NORTH AMERICA CLINICAL TRIAL SUPPLIES MARKET, COMPANY LANDSCAPE
11.1 Company Share Analysis: North America
12 COMPANY PROFILE
12.1 Thermo Fisher Scientific Inc.
12.1.1 Company Overview
12.1.2 Revenue Analysis
12.1.3 Company Share Analysis
12.1.4 Product Portfolio
12.1.5 Recent Developments
12.2 Catalent, Inc.85
12.2.1 Company Overview
12.2.2 Revenue Analysis
12.2.3 Company Share Analysis
12.2.4 Product Portfolio
12.2.5 Recent Developments
12.3 Clinigen Group Plc.
12.3.1 Company Overview
12.3.2 Revenue Analysis
12.3.3 Revenue Analysis
12.3.4 Product Portfolio
12.3.5 Recent Developments
12.4 Parexel International Corporation
12.4.1 Company Overview
12.4.2 Revenue Analysis
12.4.3 Company Share Analysis
12.4.4 Product Portfolio
12.4.5 Recent Developments
12.5 Alium Medical Limited
12.5.1 Company Overview
12.5.2 Product Portfolio
12.5.3 Recent Developments
12.6 Almac Group
12.6.1 Company Overview
12.6.2 Geographic Presence
12.6.3 Product Portfolio
12.6.4 Recent Developments
12.7 Ancillare, Lp
12.7.1 Company Overview
12.7.2 Geographic Presence
12.7.3 Product Portfolio
12.7.4 Recent Developments
12.8 Biocair
12.8.1 Company Overview
12.8.2 Product Portfolio
12.8.3 Recent Developments
12.9 Bionical Ltd.
12.9.1 Company Overview
12.9.2 Gepographic Presence
12.9.3 Product Portfolio
12.9.4 Recent Developments
12.10 Clinical Supplies Management Holdings, Inc.
12.10.1 Company Overview
12.10.2 Geographic Presence
12.10.3 Product Portfolio
12.10.4 Recent Developments
12.11 Klifo
12.11.1 Company Overview
12.11.2 Geographic Presence
12.11.3 Product Portfolio
12.11.4 Recent Developments
12.12 Movianto
12.12.1 Company Overview
12.12.2 Geographic Presence
12.12.3 Product Portfolio
12.12.4 Recent Developments
12.13 Myoderm
12.13.1 Company Overview
12.13.2 Geographic Presence
12.13.3 Product Portfolio
12.13.4 Recent Developments
12.14 Pci Pharma Services
12.14.1 Company Overview
12.14.2 Geographic Presence
12.14.3 Product Portfolio
12.14.4 Recent Developments
12.15 Sharp
12.15.1 Company Overview
12.15.2 Geographic Presence
12.15.3 Product Portfolio
12.15.4 Recent Developments
12.16 Siro Clinpharm
12.16.1 Company Overview
12.16.2 Geographic Presence
12.16.3 Product Portfolio
12.16.4 Recent Developments
13 RELATED REPORTS
LIST OF TABLES
Table 1 North America Clinical Trial Supplies Market, By Services, USD Million (2016 -2025)
Table 2 North America Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 3 North America Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 4 North America Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 5 North America Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 6 North America Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025)
Table 7 North America Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 8 North America Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 9 North America Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 10 North America Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 11 North America Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million)
Table 12 North America Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 13 North America Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 14 North America Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 15 North America Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 16 North America Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 17 North America Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 18 North America Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 19 North America Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 20 North America Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million)
Table 21 North America Clinical Trial Supplies Market, By End User, USD Million (2016-2025)
Table 22 North America Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 23 North America Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 1 North America Clinical Trial Supplies Market, By Services, USD Million (2016 -2025)
Table 2 North America Storage In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 3 North America Manufacturing In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 4 North America Packaging And Labeling In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 5 North America Distribution In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 6 North America Clinical Trial Supplies Market, By Clinical Phases, USD Million (2016 -2025)
Table 7 North America Phase Iii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 8 North America Phase Ii In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 9 North America Phase Iv In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 10 North America Phase I In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 11 North America Clinical Trial Supplies Market, By Therapeutic Uses, 2016-2025 (USD Million)
Table 12 North America Oncology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 13 North America Cardivascular Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 14 North America Dermatology In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 15 North America Metabolic Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 16 North America Infectious Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 17 North America Respiratory Diseases In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 18 North America Cns And Mental Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 19 North America Blood Disorders In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 20 North America Others In Clinical Trial Supplies Market, By Region, 2016-2025 (USD Million)
Table 21 North America Clinical Trial Supplies Market, By End User, USD Million (2016-2025)
Table 22 North America Contract Research Organizations In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
Table 23 North America Pharmaceutical And Biotechnology Companies In Clinical Trial Supplies Market, By Region, USD Million (2016-2025)
LIST OF FIGURES
Figure 1 North America Clinical Trial Supplies Market: Segmentation
Figure 2 North America Clinical Trial Supplies Market: Data Triangulation
Figure 3 North America Clinical Trial Supplies Market: Droc Analysis
Figure 4 North America Clinical Trial Supplies Market:Bottom Up Approach
Figure 5 North America Clinical Trial Supplies Market:Top Down Approach
Figure 6 North America Clinical Trial Supplies Market: Interview Demographics
Figure 7 North America Clinical Trial Supplies Market: The Market Challenge Matrix
Figure 8 Drivers, Restraints, Opportunities And Challenges Of North America Clinical Trial Supplies Market
Figure 9 North America Clinical Trial Supplies Market: Segmentation
Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025
Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025
Figure 12 North America Clinical Trial Supplies Market: By Services, 2017
Figure 13 North America Clinical Trial Supplies Market: By Clinical Phases, 2017
Figure 14 North America Clinical Trial Supplies Market: By Therapeutic Use, 2017
Figure 15 North America Clinical Trial Supplies Market: By End User, 2017
Figure 16 North America Clinical Trial Supplies Market Market: Company Share 2017 (%)
Figure 1 North America Clinical Trial Supplies Market: Segmentation
Figure 2 North America Clinical Trial Supplies Market: Data Triangulation
Figure 3 North America Clinical Trial Supplies Market: Droc Analysis
Figure 4 North America Clinical Trial Supplies Market:Bottom Up Approach
Figure 5 North America Clinical Trial Supplies Market:Top Down Approach
Figure 6 North America Clinical Trial Supplies Market: Interview Demographics
Figure 7 North America Clinical Trial Supplies Market: The Market Challenge Matrix
Figure 8 Drivers, Restraints, Opportunities And Challenges Of North America Clinical Trial Supplies Market
Figure 9 North America Clinical Trial Supplies Market: Segmentation
Figure 10 Rising Demand Clinical Trials Worldwide, Increasing Incidences Of Diseases To Drive The Market For Clinical Trial Supplies Market In The Forecast Period 2018 To 2025
Figure 11 Storage Segment Is Expected To Account For The Largest Share Of The Clinical Trial Supplies Market In 2018 & 2025
Figure 12 North America Clinical Trial Supplies Market: By Services, 2017
Figure 13 North America Clinical Trial Supplies Market: By Clinical Phases, 2017
Figure 14 North America Clinical Trial Supplies Market: By Therapeutic Use, 2017
Figure 15 North America Clinical Trial Supplies Market: By End User, 2017
Figure 16 North America Clinical Trial Supplies Market Market: Company Share 2017 (%)